EBV-Associated Intestinal Lymphomas
Case No. . | Age (yr)/Sex . | Histology . | EBV-PCR . | EBER-ISH (%) . | LMP . | CD30 . |
---|---|---|---|---|---|---|
T-cell lymphomas | ||||||
1 | 20/M | PMLC | Pos | >80 | Pos | Pos |
2 | 18/M | PMLC | NA | >80 | Neg | Pos |
3* | 24/F | PMLC EATCL | Pos | >80 | Neg | Neg |
4† | 17/M | PMLC EATCL | NA | >50 | Neg | Neg |
5 | 32/M | PMLC | NA | 20-100 | Neg | Neg |
6 | 38/F | PMLC | Pos | 5-10 | Neg | Pos |
7 | 58/M | PMLC EATCL-like | Pos | 1-5 | Neg | Pos |
8‡ | 61/M | PMLC | Pos | 5-10 | Neg | Neg |
B-cell lymphomas | ||||||
9 | 3/M | Burkitt's | Pos | 100 | Neg | Neg |
10 | 5/F | Burkitt's | NA | 100 | Neg | Neg |
11 | 65/F | CB/CC follicular | NA | 1-15 | Neg | Neg |
12 | 19/F | MALT high-grade | NA | 1-5 | Neg | Neg |
13 | 23/M | MALT low-grade | Pos | 1-5 | Neg | Neg |
Case No. . | Age (yr)/Sex . | Histology . | EBV-PCR . | EBER-ISH (%) . | LMP . | CD30 . |
---|---|---|---|---|---|---|
T-cell lymphomas | ||||||
1 | 20/M | PMLC | Pos | >80 | Pos | Pos |
2 | 18/M | PMLC | NA | >80 | Neg | Pos |
3* | 24/F | PMLC EATCL | Pos | >80 | Neg | Neg |
4† | 17/M | PMLC EATCL | NA | >50 | Neg | Neg |
5 | 32/M | PMLC | NA | 20-100 | Neg | Neg |
6 | 38/F | PMLC | Pos | 5-10 | Neg | Pos |
7 | 58/M | PMLC EATCL-like | Pos | 1-5 | Neg | Pos |
8‡ | 61/M | PMLC | Pos | 5-10 | Neg | Neg |
B-cell lymphomas | ||||||
9 | 3/M | Burkitt's | Pos | 100 | Neg | Neg |
10 | 5/F | Burkitt's | NA | 100 | Neg | Neg |
11 | 65/F | CB/CC follicular | NA | 1-15 | Neg | Neg |
12 | 19/F | MALT high-grade | NA | 1-5 | Neg | Neg |
13 | 23/M | MALT low-grade | Pos | 1-5 | Neg | Neg |